The Elevate Purdue Foundry Fund has awarded Neuro Vigor a $20,000 "Black Award" to accelerate commercialization of its drug therapy for pain in multiple sclerosis. Neuro Vigor's co-founder and chief scientist is Riyi Shi, professor of biomedical engineering and neurosciences. Shi has discovered a drug that can reduce a powerful neuro-toxin in the body, which has significant promise as a novel therapy for neuro-degenerative disease and injury.

Three Purdue University professors will be inducted in April as fellows of the American Institute for Medical and Biological Engineering. The organization will recognize Pedro Irazoqui, a professor of biomedical engineering and electrical and computer engineering, associate head of the Weldon School of Biomedical Engineering and director of the Center for Implantable Devices; Zheng Ouyang, a professor of biomedical engineering, electrical and computer engineering, and chemistry; and Ann Rundell, a professor of biomedical engineering and electrical and computer engineering.

Research by a Purdue professor was chosen as one of 2015's top technical advances by The Scientist magazine. The research was performed by Ji-Xin Cheng, a professor in Purdue's Weldon School of Biomedical Engineering and Department of Chemistry and scientific director of the Label-free Imaging lab at Purdue's Discovery Park.

Pu Wang, a post doctoral researcher at the Purdue University Weldon School of Biomedical Engineering, has been named a finalist in the 2016 InnovateHER Business Challenge by the U.S. Small Business Administration. Wang is co-founder of Vibronix Inc. with Ji-Xin Cheng, professor of biomedical engineering and chemistry. Wang was selected for his MarginPAT innovation; MarginPAT is an intraoperative assessment of breast tumor margin using a photo acoustic/ultrasound imaging system. The system provides a shorter procedure time, allowing a surgeon to clear cancer residue after removing a tumor from a breast cancer patient, which reduces the chance for a second surgery.